APTAMATRIX, INC.

Syracuse, NY · Medtech · Private

Aptamer Proteomics kit (AP-kit) for simultaneous measurement of protein abundance profiles in blood using engineered DNA/RNA aptamers with chemical modifications

Grants
$3.2M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Efficient Characterization of DNA-Protein Binding using a High-Throughput Sequencer$176,785
Federal grantDepartment of Health and Human Services · Phase II · Proteomic Analysis of Blood Plasma using High Throughput Sequencers$1,986,134
Federal grantDepartment of Health and Human Services · Phase II · Proteomic Analysis of Blood Plasma using High Throughput Sequencers$1,045,419
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
705LIFESPAN TECHNOLOGIES LLC——
706NANOMETICS LLC——
707SAFELYYOU, INC.——
708APTAMATRIX, INC.——
709Smart Diagnostics Systems LLC——
710INNOVELIX, INC.——
711CYBERLOGIC, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Library Compositions And Methosds For Acyclic Identification Of Aptamersapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.